Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Guilherme Nader Marta
Oct 10, 2024, 06:38 |
Insight
Guilherme Nader Marta: The impact of low levels of HER2 expression in the Ph3 PALLAS trial
Guilherme Nader Marta, Clinical Fellow at Dana-Farber Cancer Institute, recently shared about the Ph3 PALLAS…
Sep 24, 2024, 09:07 |
Blog
Guilherme Nader Marta: Global study on young BRCA carriers with breast cancer
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared a post by Elisa Agostinetto,…
Sep 19, 2024, 14:21 |
Insight
Guilherme Nader Marta: Evergreen study led by Diogo Martins Branco
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on X: “EVERGREEN study led…
Sep 19, 2024, 09:29 |
Insight
Guilherme Nader Marta: DESTINY-Breast06 trial out in The New England Journal of Medicine
Guilherme Nader Marta, Advanced Clinical Fellow - Dana-Farber Cancer Institute, shared a post on LinkedIn: "DESTINY-Breast06…
Jun 14, 2024, 03:24 |
Blog
Guilherme Nader Marta: Our Review On the PI3K/Akt-targeted Agents
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on X: “PI3K/Akt-targeted agents entered…
Mar 22, 2024, 16:49 |
Insight
Guilherme Nader Marta: CLEOPATRA trial analysis shows that complete response at first imaging re-evaluation correlates with longer PFS and OS
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on LinkedIn: “Many patients with…
Mar 15, 2024, 15:38 |
Blog
Elisa Agostinetto: Our last meta-analysis led by Guilherme Nader Marta shows that ctDNA detection in early breast cancer is associated with higher risk of recurrence
Elisa Agostinetto, Clinical Research Fellow at Jules Bordet Institute in Brussels, shared a post on…
Mar 13, 2024, 23:46 |
Blog
Guilherme Nader Marta: Our meta-analysis looking at the prognostic value of ctDNA in early breast cancer is now out at ESMO Open
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on LinkedIn: “Our meta-analysis looking…
Jul 19, 2023, 18:24 |
Blog
ADCs have changed the way we treat breast cancer and there is much more to come - Guilherme Nader Marta
ADCs have changed the way we treat breast cancer and there is much more to…
Jul 14, 2023, 18:15 |
Blog
Meta-analysis on the prognostic value of HER2-low in breast cancer - Guilherme Nader Marta
Now out in ESMO Open our meta-analysis led by chiara molinelli on the prognostic value of HER2-low…
1
2
All:
11
Posts:
1 - 10
Jane Fonda Breast Cancer and Non-Hodgkin Lymphoma: How She Went Against, How She Survived, and More
Inside OncoDaily Party Barcelona
Zainab Shinkafi-Bagudu has been elected as UICC President-Elect 2024-2026
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube